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Genetic Analysis of the Skin Disorder Weber-Cockayne
Type Epidermolysis Bullosa Simplex
Patrick W. Clark
05/01/2003

Summary

Weber-Cockayne Type Epidennolysis Bullosa Simplex (EBS-WC) is a rare hereditary
skin disorder characterized by intraepidennal blistering due to mechanical stress-induced
cytolysis of the basal layer keratinocytes (8,14). In comparison to other autosomal
dominant EBS subtypes, Weber-Cockayne is the least severe and is distinguished by
localized blistering of the hands and feet (3). Previous research has linked EBS-WC to
the basal layer keratin intennediate filament proteins, keratin 5 and keratin 14, and their
corresponding genes KRT5 and KRTI4, respectively (8,12). Due to the heterodimeric
nature of the keratin intermediate filaments, mutations in KRT5 or KRT14 are
responsible for the blistering phenotypes observed in EBS-WC patients (18). Linkage
analysis ofEBS-WC was perfonned by testing DNA samples from 16 members of an
affected family. Oligonucleotide primers for keratin 14 and keratin 5 were chosen and
polymerase chain reactions followed by gel electrophoresis of the amplified DNA
fragments allowed polymorphic alleles to be analyzed. The banding patterns of the
alleles indicated a strong linkage relationship between keratin 5 and affected individuals.
In addition, linkage was not shown between keratin 14 and test subjects affected by EBSWC. Based on this research, future DNA sequence analysis can be perfonned to identify
the exact mutation in the KRT5 gene affecting this particular test family.
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Introduction
Epidermolysis Bullosa (EB) encompasses a large group of hereditary skin
disorders that are characterized by their level of split or separation in the skin layers (17).
EB can be divided into three main types: EB simplex (with splitting within the basal
layer keratinocytes), junctional EB (with separation within the lamina lucida) and
dystrophic EB (with separation directly beneath the basement membrane, in the dermis)
(17). EB simplex (EBS) is usually the most common form of EB and is divided into
three different subtypes: Dowling Meara, Koebner, and Weber-Cockayne
(1,2,3,7,16,19). Weber-Cockayne Type EBS (EBS-WC) is the focus of this research and
is the mildest sUbtype characterized by localized blistering of the hands and feet (3,4,16).
Both Dowling Meara and Koebner EBS are distinguished by generalized blistering of the
entire body, and are often very debilitating (2,3,6,9,11,19).
The genetic basis of EBS-WC has evolved from several different procedures and
techniques. Clumping and aberrations of the keratin intermediate filaments in basal
epidermal keratinocytes typified early skin biopsies and ultrastructural analysis of EBS
patients (11,13). The unusual clumping and disruption of keratin filaments preceded cell
cytolysis and blister formation causing researchers to focus on the basal keratins (6,11).
One of the most important indications of basal layer keratinocytes being
responsible for EBS was determined through reverse genetics experiments involving
transgenic mice. Mice were introduced with either a KRT5 or a KRT14 mutation into
their germ line and their subsequent phenotypes exhibited all the traits characteristic of
EBS. In addition, transgenic mice studies were important in determining that not only the
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location of the mutation within the keratin gene was important, but also the type of amino
acid substitution was a critical factor in the severity of the disorder (2,4,20).
Linkage analysis is the method used in this research, and another important tool in
determining the genetic basis of EBS-WC. In the three-generation test family, linkage
analysis of the disorder in relation to polymorphic alleles within the mutated keratin gene
allows EBS-WC to be traced through the pedigree. By linking the disorder to a particular
allele, linkage to either KRT5 or KRT14 can be determined.
Unequivocal evidence that EBS-WC is caused by mutations in KRT5 or KRT14
was found by DNA sequencing of the corresponding genes from normal subjects and
EBS patients (1). Previous research has identified a number of point mutations in either
KRT5 or KRTI4, which necessitates further research in the test family of this research.
Identification of keratin 5 or keratin 14 being the underlying cause of EBS-WC
allowed tests with restriction fragment length polymorphisms (RFLP) to link EBS-WC to
the keratin gene clusters on chromosome 12 and chromosome 17 (3). The KRT5 gene
was determined to reside in the chromosome 12qll-ql3 regions, and the KRT14 gene
was isolated to the chromosome 17q 12-q21 regions (15,18).

Subjects and Methods
Subjects

All participants gave their written informed consent to take part in this study
(Appendix I). Buccal swabs were collected from 16 individuals in a three-generation
family affected by EBS-WC and were prepared for DNA analysis. Out of the 16
individuals, 10 were affected by EBS-WC, and each subject was given a number
designation to ensure confidentiality and unbiased analysis.
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Buccal Cell Preps
To prepare buccal smear preps, 600uL of 50mM NaOH was added to each
sample. The samples were vortexed and then heated at 95°C for 5 minutes. The brush
was then removed from the sample and 60uL of 1M Tris (pH 8.0) was added to neutralize
the sample. It was again vortexed and then spun in a centrifuge at 13,000 RPM for 5
minutes. The supernatant was removed and placed into a numbered tube for storage at
-20°C.
Polymerase Chain Reaction (PCR)
PCR is a very sensitive test that enables strands of DNA to be amplified and
visualized as distinct bands on various kinds of gels. One problem associated with PCR
is no single protocol is appropriate for all situations. Therefore, for each set of
oligonucleotide primers a new PCR application must be performed for optimal results.
Some of the must common problems include: no detectable product, a low yield of the
desired product, and nonspecific background bands and smears due to the formation of
primer-dimers that are incorrectly amplified. The primers chosen for both keratin 14 and
keratin 5 required different protocols and parameters that required repeated tests of trial
and error to yield the best results.
The enzyme used in the PCR was Taq DNA polymerase. The enzyme
concentration is important because if the concentration is too high, nonspecific
background products may accumulate, and if too low, not enough desired product will be
made (10). The four dNTPs were used in equal amounts at low concentrations to
minimize mispriming at nontarget sites and to reduce the probability of creating altered
DNA sequences. In addition, the concentration of magnesium had to be adjusted to
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optimize desired product. The concentration of magnesium may affect the following:
primer annealing, product specificity, formation of primer-dimers and enzyme activity
and fidelity (10).
The temperature and length of time required for primer annealing was also altered
based on several reasons. The optimum temperature for primers to anneal (Tm) was
found by the following calculation:
Tm=Th -5°C
Th = [9 (C/O) x 4°C] + [11 (AfT) x 2°C]
An accurate annealing temperature is actually 5°C below the true Tm of the designated
primers. Raising the annealing temperature of the PCR enhances discrimination against
incorrectly annealed primers and decreases the extension of incorrect nucleotides at the 3'
end of the primers. In contrast, low annealing temperatures and high dNTP
concentrations favors misincorporation of incorrect nucleotides (10).
The concentration of primers was another variable that had to be adjusted for
desired yields. If primer concentrations were too high, they promoted mispriming and
the formation of nonspecific product and primer-dimers. These misincorporations are
themselves substrates for PCR and compete with the desired product for enzyme, dNTPs,
and primers, resulting in decreased yields of the desired product (10).
Two sets of primers from previously published studies specific for the KRT14
gene were chosen that had a high rate of polymorphisms in the population. A
tetranucleotide repeat polymorphism at D 17S846 was chosen that had sufficient variation
for linkage analysis (5). The forward primer for KRT14 was designated 17-846-1 (5'TOC ATA CCT OTA CTA CIT CAO-3') and the reverse primer was designated 17-
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846-2 (5'-TCC TTT OTT OCA OAT TIC TIC-3'). The second set of primers was
designated, forward primer 17-800-1 (5'- OOT CTC ATC CAT CAO OTI TI -3') and
the reverse primer 17-800-2 (5'- ATA OAC TOT OTA CTO OOC ATT OA - 3')
(OMIM 148066).
Allele
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Figurel. Alleles and frequency of the tetranucleotlde repeat polymorphlsms amphfied by the pnmers 17846-1 and 17-846-2 (5).

Each PCR sample was run at the following parameters: 2.5 uL of lOX buffer,
7.75uL of water, 2uL of each primer, 1uL of each nucleotide, and 0.25uL of Taq DNA
polymerase. The cycle was run at 94°C for 6 minutes (initial denaturation), 94°C for 1
minute, 50°C for 1 minute (annealing), 72°C for 1 minute (extension), held at 4°C and
repeated for 30 cycles in a DNA thermal cycler.
Primer pairs for KRT5 were designed from the NCBI website (OenBank
accession number NT009609) that included a single nucleotide polymorphism (SNP).
The SNP, rs631988, has a cytosine to guanine (C/O) polymorphism. There were two
forward primers representing the C/O polymorphism and were designated Ker5-2 (5'TOA TIC CAC TIC TIC CCA OC-3') and Ker5-3 (5' - TOA TIC CAC TIC TIC
CCA OG-3'). The reverse primer for the KRT5 gene was designated Ker5-1 (5' -TCA
CAO OAO AOA AAA OAA CA-3'). Each PCR sample was run at the following
parameters: 2.5uL lOX buffer, 7.75 uL of water, 1uL of Ker5-1 and 1uL of Ker5-2 or
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Ker5-3 primers, 1uL of each nucleotide, and 0.25uL of Taq DNA polymerase. The cycle
was run at 94°C for 6 minutes (initial denaturation), 94°C for 1 minute, 53°C for 1 minute
(annealing), 72°C for 1 minute (extension), held at 4°C and repeated for 30 cycles in a
DNA thermal cycler.
Gel Electrophoresis

DNA is chemically an acid (takes a negative charge in solution) due to its
phosphate groups. Thus when an electrical field is applied to the DNA samples that have
been amplified by PCR, they migrate toward the positive charge or anode. Migration
distances are inversely proportional to the samples' molecular weight. 10uL of each PCR
reaction sample and 2uL of loading dye were inserted into wells in the top of a 10% TBE
gel and the samples were run at 100V for approximately 45 minutes in 1 X TBE solution.
The gels were then stained in ethidium bromide for 5 minutes and viewed with ultraviolet
light.
DNA Sequencing Gel

The high frequency of polymorphisms and the tetranucleotide repeat in the alleles
specified by the KRT14 primers, 17-846-1 and 17-846-2, required a DNA sequencing gel
to specify each allele. The 10% TBE gels did not allow for very specific banding
patterns, where as the sequencing gels allowed for more specificity. A PCR reaction was
performed according to the parameters specified above for KRT14 with the addition of
1uL of radioactive P32 to each sample to label the DNA. The sequencing gel was run
and exposed for varying lengths of time to yield optimum banding patterns.
The DNA sequencing gel was not run for the KRT5 alleles because heterozygotes
and homozygotes could be determined from the normal 10% TBE gels.
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Results
To determine the gene responsible for EBS-we in the test family, linkage
analysis was performed for KRT14 and KRT5. Selecting primers that had sufficient
variation in the population was critical to the success of the study. The first gene studied
was KRT14 and two different sets of primer pairs specific for the KRT14 gene sequence
were chosen. The first set of primers 17-800-1 and 17-800-2, for reasons specified in the
above methods, had either no detectable product or very low yields. Due to the lack of
results from primers 17-800-1 and 17-800-2, the next set of primers 17-846-1 and 17846-2 were used at an annealing temperature of 53°e and a concentration of 2uL per test
sample. Primers 17-846-1 and 17-846-2 yielded detectable amounts of products with
distinct bands.

Figure 2. From right to left the gel picture shows

Figure 3. From right to left the gel picture

primers 17-800 and then 17-846. The gel lanes are
labeled according to the corresponding DNA sample
number (M indicates the DNA band size marker and
B indicates a blank). The gel shows the low yield
associated with primers 17-800. Also, the bands
are of length -225 bp which is the expected band size.

shows primers 17-846. The lanes are labeled
according to their corresponding DNA sample
number (8-14).

The 10% TBE gels did not allow for determination of different alleles within the
test family, so a DNA sequencing gel had to be performed. The sequencing gel identified
5 different alleles for the amplified region of KRTI4. Each subject was labeled with their
corresponding allele and pedigree analysis showed no linkage between EBs-we and the
KRT14 gene.
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Figure 4. A DNA sequencing gel showing the 5 different KRT14 alleles represented in the test family.
Through pedigree analysis KRT14 showed no linkage to EBS-WC.
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Figure 5. The test subjects' phenotype designations along with their number designations are shown in the
sample # column. Analysis of allele segregation shows no linkage between EBS-WC and KRT14. To
show linkage, a specific allele would have to correspond to all affected subjects ('+' indicates presence of
allele in subject).
+

Since no linkage between KRT14 and EBS-WC was found in the test family, primers for
the KRTS gene were created that contained a single nucleotide polymorphism (SNP) that
allowed linkage analysis to be performed.
The primers KS-l and KS-2 amplified the cytosine residue and the corresponding
allele was designated by the numeral 2. The primers KS-l and KS-3 amplified the
guanine residue and the corresponding allele was designated by the numeral 3.
The following electrophoresis gel pictures show the banding patterns of each
subject, showing either heterozygousity or homozygousity for the SNP. For example,
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Figure 6. From left to right, the gel shows K5-1 and K5-2
Figure 7. From right to left, the gel shows
primers, test samples 2,4-6, representing allele 2. Next,
the maker then K5-1 and K5-2 primers,
primers K5-1 and K5-3, test subjects 2,4-6, represent allele 3. test samples B,5,7,8,9, representing allele 2.
Next, primers K5-1 and K5-3, test samples
B,5,7,8,9, representing allele 3.

the gel pictures show a band present for the 3 allele, but not the 2 allele for test subject 5.
Therefore, test subject 5 is homozygous for the guanine residue allele number 3. Allele
determination was performed for each test subject and the allele number was designated
on a pedigree for the test family.
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Figure 8. All 16-test subjects in the three-generation family were labeled with their subsequent allele
designation. The pedigree shows that EBS- we is linked to allele 3 in the test family. Some unaffected
subjects are heterozygous containing allele 3, but inheritance is from an individual outside of the test family
(squares represent males, circles represent females, and darkened symbols represent affected subjects).

The pedigree shows that all subjects affected with EBS-we are either
heterozygous [2,3] or homozygous [3,3], but all unaffected subjects are either
heterozygous [2,3] or homozygous [2,2]. Therefore, inheritance of EBS-We is shown to
follow allele 3 thus, linking KRT5 to the disorder.
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Discussion
The results indicate a strong probability that KRT5 is linked to EBS-WC in the
test family. The allele designated by the numeral 3 shows linkage only within affected
individuals. The heterozygous unaffected individuals also carry a 3 allele but inheritance
of the allele is from individuals outside of the affected family. Family members that are
related by marriage allow more alleles to be distributed to subsequent offspring and better
linkage analysis results. The pedigree shows that the 3 allele from unaffected
heterozygous subjects does not pass on EBS-WC. However, the pedigree does show a
direct correlation between EBS-WC and inheritance of the 3 allele from affected
individuals.
The KRT14 gene was not linked to EBS-WC by the 5 polymorphic alleles
amplified by PCR. The three-generation pedigree allowed determination that no allele
from affected individuals linked to EBS-WC. The fact that KRT5 is linked and KRT14 is
not linked corresponds to previous studies that indicate only one keratin mutation for the
majority of EBS-WC cases (3,8,9,18). Due to the heterodimeric nature of the keratin 5
and keratin 14 intermediate filaments, it is only plausible that one of the keratin genes
would contain a disruptive mutation and not both.
Future DNA sequence analysis of the KRT5 gene in the test family will hopefully
reveal the exact mutation responsible for EBS-WC. As more information is gained
regarding EBS-WC, the more probable a cure or treatment will be discovered.
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Appendix I
The Use of Cheek Cells as a Source of DNA in the Genetic Mapping of
the Skin Disorder Weber-Cockayne Type Epidermolysis Bullosa
Simplex
Introduction
This letter is to infonn you about an opportunity to participate in a graduate level
research study. The research is being perfonned as part of a graduate thesis. The study
will try to determine the DNA mutation that is responsible for causing the skin disorder
characterized by blistering of the hands and feet known as Weber-Cockayne Type
Epidennolysis Bullosa Simplex in our family. If the study is successful, the chromosome
location and the type of DNA mutation responsible for the disorder will be identified.
However, there is no guarantee that the research study will reveal any DNA mutations.
In addition, studies of Weber-Cockayne Type Epidennolysis Bullosa Simplex have been
previously perfonned, and the DNA mutations have been identified in other families.
Thus, this study is of interest to our family and will provide an opportunity for Patrick
Clark to train in this type of research, but is unlikely to provide a major step forward in
the knowledge of this disorder.

Information about your involvement in the study
If you choose to be involved in this study, the following will take place: first,
read and fully understand this fonn, next, sign the fonn in the presence of a witness, have
the witness sign the same fonn, and return it to Patrick Clark, lastly, a soft brush (swab)
will be used to collect cells from the inside of your mouth on the cheek. The swab will
be brushed on the inside of both cheeks for approximately 30 seconds. This procedure
will be prefonned twice in case of contamination of the DNA. The participant will
perfonn the procedure and the swab will be returned to Patrick Clark. The DNA will be
extracted fonn these cells in order to study the genetic skin disorder.
No additional procedures, no additional costs are necessary.

Risks
The collection of cheek cells on the swab is a routine non-invasive procedure, and
we anticipate no measurable risk to you.
Maintaining confidentiality is of the highest importance and the appropriate steps
will be taken to ensure your privacy. At no time will genetic findings be discussed,
reported, or published that are not relevant to the skin disorder.
In this study, an inheritable gene will be studied which requires the testing of both
parents and children. Thus, this testing could reveal paternity issues that are not public
knowledge.

Confidentiality
The infonnation in the study will be kept confidential. Data will be stored
securely and will be made available only to persons conducting the study. No reference
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will be made in oral or written reports that could link participants to the study. In
addition, any DNA information obtained will not be added to any forensic databases.

Benefits
There is no direct or immediate benefit to you. A benefit of the study will be
locating the gene that is responsible for causing the blistering of the hands and feet.
However, previous studies have already located the DNA mutation for Weber-Cockayne
Type Epidermolysis Bullosa.

Compensation
No compensation is available for voluntary participants of this study.
Appreciation, however, will be immeasurable.

Contact information
If you have questions at any time about the study or the procedures (or you have
experienced adverse effects as a result of participating in this study), you may contact the
researcher: Dr. Karla J. Matteson at 865-544-9449. If you have any questions about your
rights as a participant, contact the Compliance Section of the Office of Research at 865974-3466.

Participation
Your participation in this study is voluntary; you may decline to participate
without penalty or question. If you decide to participate, you may withdraw from the
study at any time.

Consent
I have read the above information. I have been informed and understand that this type of
analysis can detect when a child's biological father is not the same as the current male
parent (non-paternity). I have received a copy of this form. I agree to participate in this
study.
Participant's Signature: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date: _ _ _ __
Parent's Signature (if under 18):_ _ _ _ _ _ _ _ _ _ _ _ _ Date: _ _ __
Witness's Signature: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date: _ _ _ __
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Appendix II
The contents of this paper were submitted for credit in BCMB 409: Perspectives
in BCMB on 11/19/2002.

Genetic and Molecular Analysis of the Skin,
Emphasizing the Skin Disorder Epidermolysis Bullosa
Simplex
Introduction
Epidermolysis bullosa simplex (EBS) is a group of rare genetic skin disorders
characterized by intraepidermal cytolytic blister formation due to mechanical trauma
(18), EBS is characterized by fragility of the skin that results in severe non-scarring

blisters, and is comprised of three major subtypes and various rare types all with
autosomal dominant inheritance (20, 24), The prevalence of EBS is rare with an
estimated frequency between 1:30,000 and 1:50,000 individuals in the U.S. population
(21).
The Dowling-Meara type ofEBS (EBS-DM) is the least common and the most
severe subtype with generalized blistering of the entire body. Viewed through electron
microscopy, patients affected with EBS-DM are characterized by the presence of large
cytoplasmic clumps of tonofilaments in the basal layer keratinocytes (2,11,13). Large,
hemorrhageous blisters are present from birth, and can result in constant infections, a
failure to thrive, and neonatal death (24).
The Koebner type of EBS (EBS-K) is less severe, but still expresses generalized
blister formation of the entire body including mucous membrane blistering of the oral
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cavity (8). Koebner EBS is present at birth and increases in severity in warmer climates.
The absence of basal layer keratinocyte clumping in ultrastructural analysis helps to
distinguish EBS-K from EBS-DM (4).
The final subtype is Weber-Cockayne type EBS (EBS-WC). EBS-WC is the
most common and the mildest subtype usually localized to blistering of the hands and
feet (3), The blistering of the hands and feet, which is adversely affected by warm
climates, usually begins when a child has learned to walk or crawl lengthy distances (20).
Compared to Dowling-Meara and Koebner EBS, Weber-Cockayne EBS requires more
substantial trauma to produce blistering.

Also, like EBS-K, EBS-WC is characterized

by an absence of keratinocyte clumping in the basal layer of the skin (4).
This paper will discuss EBS through the cell biology of the skin, elucidating the
proper functions and locations of various skin structures that are important in the
expression ofEBS. In addition, the genetic basis ofEBS will be described from the
initial methodology that enabled researchers to determine the genes responsible and their
chromosomal locations. The importance of mutational location and amino acid
substitution will be highlighted to differentiate between the three main EBS sUbtypes.
Finally, the disheartening discussion of the current diagnosis and treatment of EBS will
be offset by the optimistic search for a cure that may be obtained through the use of gene
therapy.
Skin Structure and Function
The skin is a complex, multilayered organ, which produces several specialized
structures called appendages such as hair follicles, eccrine sweat glands, sebaceous
glands, and aprocrine glands (12). Variation in the skin is expressed by regional
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differences in skin thickness, composition, and density due to the regional requirements
of the skin. Thus, the palms and feet have a thick durable keratin layer, while the face
and neck have a relatively thin and pliable keratin layer (12).
There are four main layers of the skin - the epidermis, the basement membrane,
the dermis, and the hypodermis (5,9,12,22). Interaction among these layers is important
during development and for maintaining homeostasis in the adult. In many respects, the
skin layers can be best regarded as a single functional tissue and must not be regarded as
independent structures (10). However, each layer will be addressed separately to
emphasize and identify specific skin cell function and location.
The epidermis is the most complex skin layer and is a stratified, continually
renewing epithelium that is able to differentiate (12,22). The epidermis has a tough and
resilient structure that is normally able to withstand severe physical and chemical trauma.
Also, it serves to keep harmful bacteria and microorganisms out to guard against
infection, and helps to retain fluids to prevent dehydration (7). Cells that reach the body
surface are dead, enucleated, flattened cells that are shed and replaced by inner cells that
are continually moving upwards. Therefore, the epidermis is in a constant process of
self-renewal, replenishing itself approximately every 2-3 weeks (7). However, if the
epidermis is badly damaged by bums, wounds, or severe cuts it may be unable to
replenish itself. This emphasizes another important function of the epidermis, the process
of wound healing and repairs (7).
The epidermis is divided into the following zones: the basal layer, the spinous
layer, the granular layer, the transitional layer, and the stratum corneum (22). In addition,
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the epidermis is comprised of the following cell types that have embryonic origins:
keratinocytes, melanocytes, Langerhans cells and Merkel cells (5).
The basal cell layer is the lowest layer of the epidermal cells, which borders the
basement membrane (12). Basal cells, consisting primarily of keratinocytes, are the
proliferating cells of the epidermis, which after a limited number of cell divisions
terminally differentiate and move towards the skin surface, as more basal cells are
produced. Basal cells qualify as a type of stem cell because they are able to "produce
both daughter stem cells and cells that go on to differentiate to multiple celllineages"(7).
During wound healing, the rate of proliferation of these stem cells is increased and
migration to the skin surface is accelerated. Columnar in shape, basal keratinocytes
contain keratin 5 (K5) and keratin 14 (KI4) intermediate filaments providing a
cytoskeleton that has sufficient flexibility to allow cell division and migration (15).
Hemidesmosomes are proteins that are important structures in cell adhesion binding
keratinocytes to the basement membrane. This relationship is one part of epidermal
structural integrity creating support and adhesion that prevents skin fragility and blister
formation between the basal keratinocytes and the underlying dermis (22).
The spinous layer (also called the prickle cell layer) is named after the appearance
of the junctions between adjacent keratinocytes resulting in the formation of 'spines' due
to the flattening of the cell and a decrease in the size of the cell nucleus (9). The location
of the spinous layer is directly on top of the basal cell layer, towards the surface of the
skin. A particular feature of the spinous layer is the effective cohesion between adjacent
cells due to intercellular bridges. Spinous cells contain bundles of keratin filaments
organized around the nucleus and joined by desmosomes that cover the cell surface and
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provide lateral cell adhesion (21). In addition, K5 and K14 are present in the spinous
layer differentiating to keratin 1 and keratin 10 proteins as they migrate upwards from the
basal cell layer (16).
The granular layer is located on top of the spinous layer in the epidermis and is
characterized by the loss of the keratinocyte cell nucleus and the appearance of
cytoplasmic basophilic 'keratohyalin granules' (5). These granules are comprised of
dense proteins- profilaggrin and keratin intermediate filaments. The loss of keratinocyte
nuclei during keratinization, a process due to the natural maturing of keratinocytes which
is characterized by the increasing levels of keratin in the cells while they migrate to the
skin surface, is due to destructive enzyme action (21). Therefore, the granular layer
presents an area of great hydrolytic activity, which lyses most of the cytoplasmic contents
prior to the formation of the stratum corneum.
The transitional layer is an abrupt transition from the granular cell to the
terminally differentiated cornified cell (9). Several degradative enzymes have been
isolated that are involved in the destruction of cellular organelles. The granular cell not
only synthesizes, modifies, and cross-links proteins involved in keratinization, but also
initiates its own programmed destruction (5).
The final layer of the epidermis is called the stratum corneum or the keratin layer.
This layer is comprised of multiple layers of non-viable, terminally differentiated
corneocytes that differ greatly in thickness due to regional variation, sex, age, and disease
(7). The palms and the soles are the thickest regions of the keratin layer providing
increased mechanical and chemical protection. In addition to providing protection, the
stratum corneum is the major skin barrier to water loss and permeability of foreign
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substances. Corneocytes are the largest of the keratinocytes and exhibit a flattened shape
that helps provide the barrier function of the skin (5). There is a change in the structure,
composition, and function of corneocytes as they move towards the surface of the skin.
For example, the deep layer of the stratum corneum has corneocytes that are thicker and
more densely packed creating a decreased capacity to bind water. Proteolytic
degradation of the desmosomes between the outermost cells contributes to the loss or
shedding of the skin (5).
In addition to the different cell layers, various cell types are encompassed in the
epidermis. The predominant cells of the epidermis are the keratinocytes, which are
synthesized in the basal cell layer (7,12,21). Keratinocytes are cells that produce high
levels of keratin and are represented throughout the layers of the epidermis in different
stages of keratinization (21).
Melanocytes are melanin producing, dendritic cells that assume a position in the
basal layer of the epidermis (5). Lacking intercellular bridges, melanocytes do not form
junctions with keratinocytes, which allows them to extend towards the dermis. The
function of melanocytes is to produce melanin in packages called melanosomes which
transfer pigment to keratinocytes giving skin its color (5).
Langerhans cells are dendritic and the antigen-presenting cells of the epidermis
(5). They are responsible for the uptake, recognition, processing, and presentation of
soluble antigen to sensitive T lymphocytes. Langerhans cells are important in
maintaining proper immune function in the skin (12).
The fourth cell type of the epidermis is a Merkel cell. Merkel cells are
intraepithelial cells that differentiated from keratinocytes (9). Epidermal Merkel cells
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produce nerve growth factor and dennal Merkel cells express nerve growth factor
receptors contributing to the development of the skin's nervous system (5).
The epidermis is non-vascularized and receives its nutrients from blood vessels in
the underlying dermis (21). However, the epidermis and the dennis are separated by a
basement membrane that is composed of more than 50 different proteins (13). The
extracellular matrix proteins, collagen IV, fibronectin, and laminin 5, are the main
proteins of the basement membrane (7). Both the epidennis and the dennis contribute to
the cells of the basement membrane, but the basal cells of the epidennis contribute all of
the collagen IV and laminin 5 cells. The basal cells of the epidennis synthesize and
adhere to these cells as well as organize them into the basement membrane. Integrin is a
transmembrane protein that functions in cell-to-cell interactions and adhesion (5).
Integrin is an importance component of the epidermis because it acts to bind the
basement membrane by the fonnations of hemidesmosomes that link the keratin
intennediate filament cytoskeleton (9). Therefore, integrin provides great mechanical
strength and strong attachment to the basement membrane. An example of the functions
of integrin and hemidesmosomes are seen in the skin disorder junctional epidennolysis
bullosa (JEB), which causes devastating blister fonnation because of a loss of adhesion
between the epidennis and the basement membrane (7). In addition, the expression of
integrins and the attachment of basal cells to the basement membrane are required for
keratinocytes to proliferate (13).
Basal epidennal cells adhere to the basement membrane and to each other by two
different structural mechanisms. Cell adhesion to the basement membrane is provided
through specialized calcium-activated adhesion plaques called hemidesmosomes (25).
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Hemidesmosomes contain the anchoring proteins integrin, BPAG2, and BPAG Ie. The
antigen for the hemidesmosome antibody is plectin, an intermediate filament linker
protein (4). Basal epidermal cells interact laterally and suprabasally with neighboring
cells through calcium-activated membranous plaques called desmosomes. Desmosomes
are composed of distinct proteins, including desmogleins and desmocollins. The
cytoskeleton network of keratin filaments is formed through the attachments to
hemidesmosomes and desmosomes. These two adhesion plaques are relevant to the
study of EBS because studies have shown that severing the connection of the keratin
filaments to the basement membrane or to each other can result in EBS phenotypes (4).
Below the basement membrane layer of the skin lays the dermis that provides
pliability, elasticity and tensile strength to the skin (9). Maintaining a strong interrelationship, the dermis relies on the epidermis for its protection against the external
environment, and the epidermis, which is non-vascularized, relies on the dermis for its
nutrition and oxygen supply (7). Additionally, the dermis and the epidermis work
together in repair and remodeling of the skin during wound healing. The specific
functions of the dermis include protecting the body from mechanical energy, binding
water, aiding in thermal regulation, and housing receptors of sensory stimuli (5).
The dermis is less cellular than the epidermis, being composed of fibrous and
amorphous extracellular matrix surrounding the appendages (such as hair follicles),
neurovascular networks, sensory receptors and dermal cells (9). There are two main
types of connective tissue that are found in the dermis: fibrous and non-fibrous. Collagen
and elastic tissue are the main types of fibrous tissue and filamentous glycoproteins,
proteoglycans, and glycosaminoglycans are the three main types of non-fibrous tissue.
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Collagen is the major constituent of the dermis and the skin accounting for
approximately 77% of the skin's dry weight and providing necessary elasticity and tensile
strength (9). There have been more than 20 different collagens identified, each composed
of three chains that may be the same or very distinct from each other. However, the
majority of the collagens are types I, III, and IV.
Elastic fibers are the second form of fibrous tissue and are involved in restoring
skin to its normal configuration after it has been stretched or deformed. It is a continuous
network of tissue that extends from the lamina densa throughout the dermis and into the
connective tissue of the hypodermis.
The non-fibrous glycoproteins, glycosaminoglycans, and proteoglycans of the
dermis surround the fibrous tissue and provide a gel-like milieu in which cells can
migrate (5). These fibers help to regulate the water-binding capabilities of the dermis and
regulate dermal volume and compressibility. In addition, through binding growth factors
and cytokines the non-fibrous tissue acts to influence proliferation, differentiation, tissue
repair and morphogenesis (22).
The primary cell type of the dermis is the fibroblast, a cell that migrates through
the tissue and is responsible for the synthesis and the degradation of fibrous and nonfibrous connective tissue proteins (5). The ability of fibroblast cells to differentiate
imparts great importance in their regulation because of increased proliferation and
synthetic activity in wound healing and during the formation of scares.
The dermis is divided into two distinct regions: the upper papillary dermis and the
lower reticular region. The difference in the two dermal regions is based on connective
tissue organization, cell density and nerve and vascular patterns (9). A layer of vessels,
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the subpapillary plexus, marks the boundary between the papillary and reticular regions
of the dermis.
The upper papillary dermis is the thinner region comprised of bundles of collagen
fibrils and elastic fibers. It is the outermost portion of the dermal connective tissue
attaching to the basement membrane via anchoring fibrils such as collagen VII, and
conforms to the epidermal ridges and grooves of the epidermis (9). The loose
distribution of fibrils and the large amount of interlibrillar gel allows the papillary dermis
to accommodate for mechanical stress. Also, the high density of fibroblasts in this region
allow for a high rate of cell proliferation and metabolic activity (9).
The lower reticular dermis is the largest component of the dermis and the skin
(13). It is constituted by large collagen and elastic fibers that form a dense layer with
little vascular tissue and less fluidity. The mature elastic fibers form a structure around
the interwoven strands of collagen fibers. The two fiber systems are integrated,
providing the dermis with strong mechanical support. Progressively, the collagen and
elastic fibers increase in size and density as they approach the hypodermis (5).
The final layer of the skin is called the hypodermis, composed of adipose tissue,
which functions to insulate the body, store energy supplies, and cushion and protect the
skin (5). It also has a cosmetic effect in molding to body contours. The deep boundary
between the dermis and the hypodermis is defined by the transition from fibrous to
adipose connective tissue.
Epidermal Keratins
Previous studies have shown that EBS is caused by a functional abnormality in
the basal cell layer keratin proteins (3,19,20). Therefore, it is important to understand the
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normal structure and function of epidermal keratins in order to comprehend how the
keratin gene mutations cause abnormal structure and subsequent protein function leading
to the skin disorder EBS. The cellular architecture of the epidermis is comprised of
keratins that are essential for protective barrier function (7). A comprehensive approach
to keratin proteins will be taken with a focus on the keratin 5 and keratin 14 proteins
located in the basal cell layer of the epidermis.
Keratins make up the intermediate filaments, which have a diameter of 8-10 nm,
that are the ubiquitous components of the cytoskeletons of epithelial cells (16). They
form a class of resistant, insoluble proteins that are found in epithelium, hair, feathers,
claws, and horns (15). The term keratinization is given to the process that causes these
tissues to become tough and insoluble. In the human species, 30 different types of
keratin protein chains are known to be expressed (13,23).
Keratins have been classified into two types based on their isoelectric points (pH
4.5-7.5): acidic (type I) and basic (type II). The keratins of one type are more closely
related to each other than to keratins of the other type (2,15,23). Also, intermediate
filaments are formed as components of both types being paired together based on
molecular size (40-70 kDa) (11,15). On the basis of the amino acid sequence, the small
(40-56.5 kDa) and relatively acidic keratins form the type I class and the larger (53-67
kDa) and more basic keratins form the type II class (2,16,26).
Amino acid sequence analysis has helped to elucidate that keratin filament
assembly involves a three-chain composition (9). The primary structure of a keratin is
the central alpha helical rod domain made up of seven amino acid repeating units (2).
This central region of approximately 310 amino acid residues is not continuous,
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consisting of four alpha helical domains that are linked to each other by three regions of
beta turns, which are helix disruptions (16,23,26). These linker segments are non-alpha
helical regions that are not highly conserved. The alpha helices are highly evolutionarily
conserved sequences of the keratin proteins (6). The alpha helical domains of the
intermediate structure are involved in the formation of the coiled-coil structure of
epidermal keratins and are two-stranded structures composed of equimolar amounts of
one type I and one type II keratin protein. Biochemical studies have shown that the
polypeptide chains in each heterodimer are parallel and in exact axial register providing
support for the two-stranded alpha helical structure (16). Intermediate filaments are
formed from parallel, coiled-coil dimers, and more than 10,000 of these dimers are
needed to make each 10-nm filament (16). Dimers associate in a head-to-tail fashion to
make linear arrays that pack into antiparallel chains called protofilaments (2-3nm).
Protofilaments intertwine to form protofibrils (4.5nm), and approximately four of these
constitute the overall10-nm diameter of the intermediate filament (16). Intermediate
filaments are named because of their 10-nm diameter is intermediate between that of
microfilaments (6-nm) and microtubules (23-nm) (6).
Keratin intermediate filaments provide a flexible intracellular network that
functions to provide cell shape and structure and to resist stresses applied by external
forces (6). Mutations that weaken the structural framework provided by keratin
intermediate filaments increases the risk of cell rupture and the formation of blisters.
Keratins, like all proteins, have an amino terminal and a carboxyl terminal. The
degree of homology within the central helical domains of all keratins of a single type
implies that all of the interior coiled-coil regions are similar and that the differences in
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keratin intermediate filaments must reside in the heterogeneous amino and carboxyl
termini (15). The termini in basal epidermal keratins are rich in glycine and serine giving
rise to a flexible cytoskeleton required for dividing and metabolic activity. This differs
from the disulfide bond cross-bridges that are formed in cysteine-rich termini of hair and
wool keratin filaments (6). In addition, differences in keratin intermediate filaments are
found in the molecular weight of the carboxyl and amino termini. The different regions
of keratin intermediate filaments are assigned domain titles (16). The amino terminal
sequences are called the 'head' region, and the carboxyl terminal sequences are called the
'tail'region. The four alpha helices are designated as the 'rod' region named in
sequential order of the amino acid sequence: lA, 1B, 2A, and 2B (19). The three nonalpha helix regions are termed 'linker' segments and are designated L1 (2.5nm), L12
(1.6nm), and L2 (O.Snm), respectively (2,11).
Not only is there a pronounced difference in weight and length of these nonhelical
termini segments of different intermediate filaments, but there is also tremendous
variation in the amino acid end sequences. Even in terminal sequences of two
intermediate filaments of the same type, there is little homology due to numerous gaps
and insertions (16).

Thus, the major differences in keratin intermediate structures of all

types are found in the nonhelical terminal regions and not in the central alpha helices.
Analysis of intron sequence position in the keratin genes shows conservation over
millions of years of evolution and must indicate that there are strict constraints against
varying the lengths of the internal exons of the intermediate filament genes (16).
Homology between different intermediate filaments is very high, especially at the
beginning of helix 1A and at the end of helix 2B.
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The degree of homology of intermediate filament rod domains emphasizes the
importance of the linker regions in forming the coiled-coil dimer, and in recognizing their
perspective partners in dimer and tetramer formation (23). Deletions in the linker regions
do not prevent dimer and tetramer formation, but they do interfere with filament stability
and proper keratin function.
The diversity of the head and tail regions contribute to the differences in keratin
filaments and are tailored to suit a particular 10-nm filament network. One general role
shared among the tail domains of keratins is to stabilize protein-protein interactions
between intermediate filament subunits. However, the role of the head domain is more
complex playing a role in the spartial alignment of subunits during intermediate filament
assembly. In addition, portions of the head and tail regions extend along the surface of
intermediate filaments interacting with various cell structures and organelles (6).
Studies Leading to the Genetic Basis of Epidermolysis Bullosa Simplex
Early ultrastructural studies of patients with severe blistering found an unusual
clumping of keratin intermediate filaments that preceded cell cytolysis and blister
formation (13). Also, studies showed that shortened keratin filaments led to a disruption
of the keratin network and intermediate filament assembly (8). Since clumping of keratin
filaments preceded blister formation and cytolysis, it was postulated that EBS was likely
to arise from structural defects in the epidermal keratins. The most important evidence
indicating that keratin mutations were responsible for blistering disorders came from a
reverse genetics experiment where mice were introduced with a mutant keratin K14 gene
into their germ line. The transgenic mice exhibited nearly all of the phenotypic and
biochemical traits characteristic of EBS-DM, including mechanical stress induced

30

blistering over the body sutface, clumping of keratin filaments, and cytolysis of the basal
layer cells (2,25). In mice, the human keratin gene was appropriately expressed in the
basal layer of the epidermis and other stratified squamous epithelia. Transgenic mice
were important in identifying both the keratin K14 gene and the keratin K5 gene as being
responsible for EBS. The mutation in transgenic mice caused aberrations similar to those
in cultured EBS keratinocytes demonstrating that the mutations in K14 were responsible
for the disease (3). In addition, strategically engineered mutations in various positions on
the K5 and K14 genes indicated the relationship between mutation location and the
severity of the disorder (4). When transgenic mice were engineered with mutations that
expressed low-level keratin mutations, observed phenotypes were more similar to EBS-

we with blistering predominately on the paws.

In the same fashion, when severe

disruption of keratin filament assembly was induced, phenotypes were observed that
corresponded closely to EBS-DM, with total-body trunk blistering (4).
Another study that helped researchers determine the genetic basis of EBS
involves genetic linkage analysis (1). Families affected with EBS were studied for
inheritance of keratin intermediate filament abnormalities. The researchers found that the
inheritance ofEBS was linked to keratin genes K5 and K14 (1).
Unequivocal evidence that human EBS can arise from genetic defects in K14 and
K5 came from sequencing the corresponding genes from normal patients and EBS
patients and from conducting mutational functional analysis of the defects. A number of
point mutations in either of the keratins K5 or K14 were identified. As expected from the
heterodimeric nature of the basal layer keratin filaments, EBS can arise from defects in
the K14 or K5 genes (1).
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Genetic Analysis of EBS
EBS is caused, in most cases, by missense mutations in the K5 and K14 genes
(10). More than 50 different keratin mutations have been discovered highlighting the
existence of mutational "hotspots" (14). Keratin proteins that have sequence changes in
these hotspot regions that encode the helix initiation and termination sequences are more
likely to have detrimental protein function. Mutations that occur outside these hotspots
are usually less severe disease phenotypes, such as EBS-WC (11). However, some
studies have observed nonsense mutations that resulted in premature stop codon
mutations of K14 and K5 (10). One example of a mutation that resulted in the expression
of EBS-DM was observed in a patient that carried a heterozygous A to G transition at
nucleotide position 368, changing asparginine to serine at codon 123 (22).
Once the keratin 5 and keratin 14 genes where identified as the underlying cause
of EBS, restriction fragment length polymorphisms (RFLPs) were used to link EBS to the
keratin gene clusters on chromosome 12 and chromosome 17 (3). Linkage analysis and
improved markers demonstrated that the genetic defect in EBS mapped to the locations of
known loci for epidermal keratin type I and type II clusters. The keratin 5 gene was
determined to reside in the chromosome 12qll-ql3 region, and the keratin 14 gene was
isolated to the chromosome 17q12-q21 region (3,4,24).
There is a strong correlation between the severity of the EBS disease, the location
of the EBS mutation with respect to keratin structure, and the degree to which a particular
mutation disrupts filament assembly. EBS-DM and EBS-K are characterized by
mutations that occur in the conserved alpha helical regions of the keratin proteins. In
particular, EBS-DM associated mutations reside in the highly conserved ends of the lA
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or 2B segments, whereas EBS-K associated mutations are usually located more centrally
in the less conserved rod domains. EBS- we mutations are most frequently in the nonconserved regions such as the linker region L12, in the head region of K5, or in the 2B
segment of K14 (22).
There is a strict genotype-phenotype correlation in EBS, whereas the same
mutation will always result in a single phenotype (22). The location of the keratin
mutation is important, yet it is not possible to predict the resulting phenotype merely by
the position of the mutation. The other critical factor in determining the severity of the
EBS phenotype is the nature of the amino acid substitution (10). For example, studies
have shown how two different mutations in the same location of the keratin gene result in
drastically different functional consequences on the keratin intermediate filament. For
instance, differences may arise because one mutation resulted in a hydrophobic amino
acid substitution and the other mutation resulted in a hydrophilic amino acid substitution
altering the arrangement of the keratin intermediate filament (22).
The autosomal dominant mode of inheritance characterized in EBS arises because
mutant keratins are able to recognize their obligatory heterotypic partners and act in a
dominant negative fashion to disrupt keratin network formation. For instance, a person
affected by EBS- we receives a normal allele from the unaffected parent and a mutated
allele from the affected parent. Autosomal dominant diseases are not sex -linked and
affected parents have a 50% chance of passing on the genetic mutation to their offspring.
The cytolysis of basal cells is linked to the lack of a proper keratin filament
network. Without the cytoskeleton structural support of the keratin intermediate
filaments, basal cells become fragile and are prone to breakage upon mechanical stress
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(4). Functional demonstration of this has come through studies of mice and humans that
have a null mutation in K14 and lack a typical basal cell keratin network (2). Since K5
and K14 form obligatory heterodimers, in the absence of K14, K5 cannot assemble into
keratin filaments. However, K5 is present but in very low abundance forming wispy
filaments within the basal epidermal cells. Interestingly, the patients and the mice
lacking K14 expression have less severe blistering than those with severely disrupting
dominant-negative mutations, suggesting that aggregates of insoluble keratin worsen the
cell degeneration in EBS cases. In EBS- we cell rupturing occurs in a defined zone,
beneath the nucleus and above the hemidesmosomes, which is within the region of
greatest structural strain where the cytoskeleton spans the distance between the nucleus
and the plasma membrane (21).
Unique Features of EBS
A unique feature of EBS- we is that blisters generally heal without scarring. In
mice studies, it has been shown that during wound-healing, basal cells flatten, reduce
their levels of K5 and K14 synthesis, and do not lyse (4). These results support the idea
that lysis is a mechanical trauma-dependent phenomenon that is likely to occur from a
compromise in mechanical integrity, and that mechanical stress may be greater when
cells are columnar than when cells are flattened (4).
Research has indicated that EBS- we worsens in hot climates especially during
the humid summer months (3,4,17). The increased blister formation could be due to
temperature-sensitive changes in the mechanical integrity of basal cells, particularly
because of their high level of fluidity. It is also known that induction of heat-shock
proteins can induce alterations in keratin filament networks in simple epithelial cells. In
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addition, the stability of the keratin network or its interactions with other cellular
components could change in a temperature dependent fashion.
One of the most interesting features of EBS-DM and EBS-K is that the
phenotypic expression of the disease improves with age (4,17). There are several
possible theories to explain this feature, but the most likely explanation is that mechanical
stress on basal cells is the greatest during development. In neonatal skin, the cellular
anchors of the epidermis are much smaller, and the support structures are not fully
formed. Therefore, maturation is likely to improve the mechanical strength of the skin,
lessening basal cell fragility (4).
Diagnosis and Therapy of EBS

Methods for diagnosis of EBS are very reliable, and often a preliminary diagnosis
can be made after a routine patient exam. Easy blistering at birth or in childhood due to
mild mechanical trauma and the healing of wounds without scarring are signs that a
patient might have EBS (1). However, for an accurate diagnosis ultrastructural analysis
of a skin biopsy from a lesion is required. The ultrastructural analysis will reveal
intraepidermal cytolysis of the basal cell layer without perturbations in the suprabasal
layers. In addition, EBS-DM is distinguished through clumping of the keratinocytes,
which is not seen in EBS-K and EBS-we (11).
Visual analysis is still used to distinguish between the mildest and most severe
EBS SUbtypes. EBS-We is largely restricted to the hands and feet whereas EBS-DM and
EBS-K exhibit more generalized blistering over body trunk areas. EBS-DM is more
severe than EBS-K and frequently is characterized by clustered lesions and cutaneous and
oral cavity anomalies (21).
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The accumulation of genetic data has made it possible to develop DNA screening
methods for the diagnosis of EBS and for genetic testing within an affected family.
Given that most EBS mutations are clustered in the K5 and K14 rods, it is possible to
rapidly identify the key mutation within most EBS families, through the use of either
polymerase chain reaction (PCR) analysis and sequencing of genomic DNA or through
immunologic tools to distinguish the normal sequences from the mutated sequences in the
keratin genes (21). Once the location of an EBS mutation has been identified in an
affected parent, it enables future prenatal diagnosis (18). As in vitro methods are
developed to distinguish normal and mutant embryos, it may be possible in the future to
eliminate the disease in future offspring of an EBS family.
Future Treatments of EBS
There is currently no cure for EBS and therapeutic methods have been largely
ineffective. Clinical treatment of children with EBS-DM is the most challenging to
physicians and family caregivers because of its debilitating effects. Great care has to be
taken to prevent physical trauma and bacterial infections during the first several years of
life. In most cases, sterile bandages and antibiotic ointments are used to guard against
infection. Since blistering is made worse by heat, a cool environment is important.
The epidermis appears to be a feasible target for tissue for gene therapy because it
is readily accessible and can be easily removed in the event of unwanted effects (13). In
addition, the epidermis is continually renewing through the activity of stem cells in the
basal cell layer. This creates the possibility of transducing these stem cells for a longterm treatment of patients. However, gene therapy is still a very new concept and many
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problems are yet to be answered including the mode of gene delivery and controlling the
differentiation of stem cells (13).
Transgenic mice studies have also been important in showing that EBS may be a
disease amenable to gene therapy (4). In mosaic transgenic mice, in which the mutant
human keratin gene is integrated into the mouse's chromosomal DNA after the first cell
division of the embryo only a fraction of the transgenic animal's epidermal cells
contained the mutant gene, while the remainder were wild type. Given these findings it
appears there is a strong natural selection pressure against the mutated cells. When
healthy wild-type cells are transplanted in the presence of mutant EBS cells, the healthy
cells seem to rapidly replace basal layer vacancies left by ruptured EBS cells. By
developing methods to engineer out or replace the mutant keratin gene in cells cultured
from an EBS patient, cultured now-healthy epidermal skin grafts could replenish affected
areas (4). In addition, future improvements in homologous recombination techniques
may allow researchers to remove or inactivate the point mutations responsible for most
EBS subtypes (13). Thus one of the problems associated with gene therapy is developing
the technology for rapidly engineering out a defective keratin gene from the
keratinocytes.
Conclusion
Epidermolysis Bullosa Simplex has proven to be a disease that is very
debilitating, painful, and limiting of affected individuals' daily lives. However, by
studying diseases such as EBS, that have a strong genetic basis and complex cell biology,
researchers are able to gain a better understanding of human biology and disease. For
example,

analysis of the skin from a genetic and molecular perspective has underscored
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the importance of cell adhesion, keratin intermediate filament structure and assembly,
and tissue architecture in contributing to the proper balance, differentiation, and function
of the epidermis. The combination of human biology and genetics will allow future
treatments and cures to be discovered for many diseases that are presently incurable.
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